Compression Garments in the Community With POTS
University of Calgary
30 participants
May 17, 2021
INTERVENTIONAL
Conditions
Summary
Compression Garments are a commonly prescribed treatment in Postural Orthostatic Tachycardia Syndrome (POTS). The effectiveness of a proof-of-concept compression garment has been demonstrated in an acute laboratory setting. It is not known if commercially available compression garments that participants wear in their every day lives are effective at improving heart rate and reducing symptoms in POTS. This trial will evaluate the use of commercially available waist-high and abdominal compression garments in adults diagnosed with POTS in a community setting.
Eligibility
Inclusion Criteria5
- Physician diagnosis of Postural Tachycardia Syndrome (POTS)
- Resident of Canada
- Owns waist-high compression garment: medical grade or commercially available tights with a pressure rating provided (e.g. 15-18 mmHg, 20-30 mmHg, 30-40 mmHg)
- Optional Sub-Study: owns an abdominal compression garment (e.g. abdominal shapewear, waist high shorts)
- Able to participate in a 4-day study (2x2 day segments with a 5-day washout period)
Exclusion Criteria7
- Overt cause for postural tachycardia (i.e., acute dehydration, thyroid disease) that precludes POTS diagnosis
- Not a resident of Canada
- Participants with somatization or severe anxiety symptoms will be excluded
- Pregnant (self-reported)
- Inability to tolerate compression garments for the duration of the study
- Does not own a waist-high compression garment
- Other factors which in the investigator's opinion would prevent the participant from completing the protocol, including poor compliance during previous studies
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Waist-high compression tights providing 15-40 mmHg of pressure.
Abdominal compression garment compressing the abdomen, buttocks, and upper thighs.
Medications that modulate heart rate and blood pressure that participants regularly take. These medications include beta-blockers, midodrine, ivabradine and stimulants.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04881318